by Darrell Ward, The Ohio State University Bar graph displaying mean startle magnitude during each task condition, across both lab sessions. PBO placebo, SUV 10 mg suvorexant. Bars reflect two standard errors. Credit: Translational Psychiatry (2022). DOI: 10.1038/s41398-022-02090-x Clinicians and researchers have known for some time that uncertainty fuels anticipatory anxiety—that heightened sense of caution and vigilance when...
Artificial intelligence identifies severe aortic stenosis from routine echocardiograms
by European Society of Cardiology Micrograph showing calcific aortic stenosis, abbreviated CAS. Nephron/Wikimedia Commons, CC BY-SA 3.0 A novel artificial intelligence (AI) algorithm uses routine echocardiograms to identify aortic stenosis patients at high risk of death who could benefit from treatment. The late breaking research was presented in a Hot Line session on 28 August at ESC Congress 2022....
How Quickly Can You Get Infected With Omicron After An Exposure?
By Jillian Wilson Aug 29, 2022, 05:45 AM EDT D3SIGN VIA GETTY IMAGES The amount of time it takes to start experiencing COVID symptoms if you’re infected is shrinking. Early in the pandemic, an exposure to COVID meant waiting anxiously for many days to see if you were infected. Now, the window is getting smaller...
Stem Cell Transplant, CAR-T Combo May Improve Lymphoma Survival
M. Alexander Otto, PA, MMS August 26, 2022 The study was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Combining autologous stem cell transplantation with anti-CD30 chimeric antigen receptor T-cell therapy is a highly effective treatment for relapsed/refractory CD30+ lymphoma, even for patients with PET-positive and chemorefractory disease. Why This Matters...
New rheumatoid arthritis drug passes Phase 3 trial, looks to approval
By Rich Haridy August 25, 2022 The new treatment is hoped to be available within the next 12 months Depositphotos Research published in The New England Journal of Medicine has reported positive Phase 3 trial results for a new monoclonal antibody treatment targeting rheumatoid arthritis. The novel therapy is hoped to offer a new option for patients...
What is Bladder Exstrophy-Epispadias-Cloacal Exstrophy Complex?
By Danielle Ellis, B.Sc. Reviewed by Aimee Molineux Bladder exstrophy-epispadias-cloacal exstrophy complex is the most severe form of the BEEC (Bladder exstrophy-epispadias complex), constituting 10% of all the cases. In this condition, an abdominal wall defect causes bladder and large intestine extrusion, leading to anal, genital, and colon abnormalities. BEEC is a rare, congenital, multisystemic...
Mining Ultrasound Data to Improve Liver Diagnostics: Interview with Beth Rogozinski, CEO at Oncoustics
AUGUST 23RD, 2022 CONN HASTINGS EXCLUSIVE, ONCOLOGY, RADIOLOGY Oncoustics, a medtech company based in Ontario, Canada, developed the OnX Liver Assessment Solution, an AI-powered ultrasound-based diagnostic system for liver disease. At present, detecting liver disease is a challenge, potentially involving high-end imaging systems, specialists, and invasive biopsies. These challenges, and the related expense, can limit patient...
Smart Socks Help Prevent Falls Among At-Risk Patients
AUGUST 25TH, 2022 CONN HASTINGS GERIATRICS, REHAB, SURGERY, TELEMEDICINE Researchers at the Ohio State University Wexner Medical Center have tested the PUP (Patient is Up) Smart Socks, developed by a medtech company called Palarum, in their ability to reduce falls among at-risk patients. The socks contain pressure sensors that alert caregivers when a patient is attempting to...
“Polypill” reduces cardiovascular mortality by 33% in patients treated after a heart attack
THE MOUNT SINAI HOSPITAL / MOUNT SINAI SCHOOL OF MEDICINE IMAGE: DR. FUSTER LED THE SECURE STUDY WITH RESULTS PRESENTED AT EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2022 AND PUBLISHED IN NEW ENGLAND JOURNAL OF MEDICINE CREDIT: MOUNT SINAI HEALTH SYSTEM A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular...
Heavy smoking and smoke inhalation may worsen impact of heart attacks
EUROPEAN SOCIETY OF CARDIOLOGY Barcelona, Spain – 26 Aug 2022: The risk of death or poor prognosis after a heart attack is more than 20-fold higher in smokers with exhaled carbon monoxide levels above 13 ppm, indicating heavy smoking and inhalation of smoke. That’s the finding of late-breaking research presented at ESC Congress 2022. “The...